01Research Directions

L-Citrulline Malate 2:1 research directions

01Research Directions

Why this compound has a literature

Citrulline malate is a combination of L-citrulline and malic acid, conventionally supplied at a 2:1 citrulline-to-malate ratio. It occupies an unusual position in the sports-nutrition literature: a body of acute resistance-exercise trials was conducted on the combination as a single ingredient, and only recently have investigators begun to test whether the malate moiety contributes anything beyond the citrulline. For a purchaser, the important structural feature of this literature is that many of its underlying mechanistic claims rest on the citrulline component, which has its own separate and larger evidence base.

02Literature

What the literature investigates

The acute repetitions-to-failure literature and its inconsistency

The dominant study design in this area is a single pre-exercise dose followed by sets to voluntary failure. Vårvik, Bjørnsen and Gonzalez (2021) meta-analysed eight double-blind placebo-controlled studies (137 participants) and reported that 6-8 g taken 40-60 minutes before exercise was associated with three more repetitions on average, a 6.4 ± 7.9% difference with a small standardised mean difference of 0.196; the lower-body subanalysis reached only a trend and the upper-body subanalysis was not significant. Aguiar and Casonatto (2022) meta-analysed four randomised controlled trials covering 138 assessments in resistance-trained adults and did not observe an overall effect favouring citrulline malate on muscle strength outcomes. Gough et al. (2021) reviewed the field critically and characterised results across resistance-exercise and cycling studies as equivocal, with a single acute 8 g dose the most common protocol. Wang et al. (2026) subsequently applied a three-level meta-analytic model across exercise-performance outcomes.

Does the malate contribute? Direct comparisons

This is the question most specific to the 2:1 material and it is only now being addressed directly. Martín-Olmedo et al. (2025), in a randomised double-blind placebo-controlled crossover in forty-three trained men and women, gave placebo, 5.3 g citrulline, or 5.3 g citrulline plus 2.7 g malate 45 minutes before three sessions and reported that neither condition improved maximal neuromuscular performance, ballistic strength, strength-endurance or exertion perceptions. Bayat et al. (2025) ran a six-week trial in thirty-three resistance-trained men comparing 8 g/day L-citrulline, 12 g/day L-citrulline DL-malate and placebo, and reported significant differences from placebo for total upper-body repetitions to failure in both active arms. The older mechanistic rationale traces to Bendahan et al. (2002), who used 31P magnetic resonance spectroscopy in eighteen men during 15 days of 6 g/day citrulline/malate and attributed observed changes to an enhanced malate supply feeding tricarboxylic acid cycle anaplerosis — a proposed mechanism rather than a demonstrated ingredient comparison.

Ratio, salt nomenclature and what the papers actually dosed

Reading this literature for procurement purposes requires attention to what was actually administered. Published protocols variously describe 'citrulline malate', 'citrulline/malate' and 'L-citrulline DL-malate', and the ratio is not always stated; Bayat et al. (2025) matched 12 g/day of the malate form against 8 g/day of free citrulline, which is consistent with a 2:1 basis, whereas Martín-Olmedo et al. (2025) dosed the citrulline component identically across arms and varied only the malate. Gough et al. (2021) specifically flagged inconsistency in dosing and reporting as a limitation of the field. A further complication is that malic acid may be supplied as the DL racemate rather than the L form. In practice, two products both labelled '2:1' can differ in free-citrulline delivery, and papers cannot be compared without normalising to citrulline content.

Mechanistic evidence that belongs to the citrulline component

Much of the physiological rationale offered for this ingredient is drawn from work on citrulline itself. Gonzalez and Trexler (2020) reviewed the citrulline literature and reported that oral L-citrulline and citrulline malate supplementation increase plasma citrulline and arginine concentrations along with total nitrate and nitrite concentrations, framing citrulline as an arginine precursor that avoids the presystemic elimination affecting oral arginine. Purchasers evaluating supplier documentation should note the direction of inference here: evidence that citrulline raises plasma arginine is evidence about citrulline, and does not by itself establish anything about the malate portion of a 2:1 complex. The citrulline-specific literature is treated separately on the L-citrulline page.

03Specification

What this means when you specify the material

Published protocols cluster at 6-8 g of the combination taken 40-60 minutes pre-exercise for acute designs, and 12 g/day in the six-week comparison. Because the trials express dose inconsistently, specify and verify citrulline content on the certificate of analysis rather than relying on the '2:1' label alone, and confirm whether the malic acid is L- or DL-. The malate portion also lowers solution pH relative to free citrulline, which affects flavour system and beverage stability work, and the reported effect sizes in the meta-analyses are small enough that dose accuracy matters when reproducing a published protocol.

04References

Cited literature

Research context only. Each entry describes what a published study examined and reported. These are not claims about this raw material, and not claims about any finished product. Regulatory and labelling judgements belong to the brand placing the product on its market.

A critical review of citrulline malate and exercise performance noted that a single acute 8 g dose has been the most common protocol, flagged inconsistency in dosing and reporting across studies, and characterised results across resistance-exercise and cycling studies as equivocal. Gough LA, Sparks SA, McNaughton LR, Higgins MF, Newbury JW, Trexler E, Faghy MA, Bridge CA. Eur J Appl Physiol. 2021;121(12):3283-3295. PMID 34417881 DOI 10.1007/s00421-021-04774-6
A systematic review and meta-analysis of eight double-blind placebo-controlled studies (137 participants) reported that 6-8 g of citrulline malate taken 40-60 minutes before exercise was associated with three more repetitions on average (6.4 ± 7.9%, standardised mean difference 0.196), with the lower-body subanalysis reaching only a trend and the upper-body subanalysis not significant. Vårvik FT, Bjørnsen T, Gonzalez AM. Int J Sport Nutr Exerc Metab. 2021;31(4):350-358. PMID 34010809 DOI 10.1123/ijsnem.2020-0295
A meta-analysis of four randomised controlled trials (138 assessments) in resistance-trained adults did not observe an overall effect favouring citrulline malate supplementation on muscle strength outcomes. Aguiar AF, Casonatto J. J Diet Suppl. 2022;19(6):772-790. PMID 34176406 DOI 10.1080/19390211.2021.1939473
A randomised double-blind placebo-controlled crossover trial in forty-three trained men and women compared placebo, 5.3 g L-citrulline, and 5.3 g L-citrulline plus 2.7 g malate taken 45 minutes before testing, and reported that neither active condition improved maximal neuromuscular performance, ballistic strength, strength-endurance, or exertion and emotional perceptions. Martín-Olmedo JJ, Miras-Moreno S, Cuadra-Montes K, García-Ramos A, Ruiz JR, Jurado-Fasoli L. Int J Sport Nutr Exerc Metab. 2025;35(2):89-98. PMID 39662304 DOI 10.1123/ijsnem.2024-0006
A six-week double-blind placebo-controlled trial in 33 resistance-trained men compared 8 g/day L-citrulline with 12 g/day L-citrulline DL-malate and placebo, and reported significant differences from placebo for total upper-body repetitions to failure in both active arms. Bayat D, Azizi M, Behpour N, Tinsley GM. J Int Soc Sports Nutr. 2025;22(1):2513944. PMID 40470618 DOI 10.1080/15502783.2025.2513944
In eighteen men reporting fatigue without documented disease, 15 days of 6 g/day citrulline/malate was studied with 31P magnetic resonance spectroscopy of the flexor digitorum superficialis; the authors reported increases in the rate of oxidative ATP production during exercise and in phosphocreatine recovery rate, and attributed these to an enhanced malate supply activating tricarboxylic acid cycle anaplerosis. Bendahan D, Mattei JP, Ghattas B, Confort-Gouny S, Le Guern ME, Cozzone PJ. Br J Sports Med. 2002;36(4):282-289. PMID 12145119 DOI 10.1136/bjsm.36.4.282
A systematic review and three-level meta-analysis examined the effects of citrulline malate supplementation across exercise-performance outcomes. Wang X, Fan X, Chang J, et al. Nutrients. 2026;18(12):1881. PMID 42356270 DOI 10.3390/nu18121881
A review of the citrulline literature reported that oral L-citrulline and citrulline malate supplementation increase plasma citrulline and arginine concentrations along with total nitrate and nitrite concentrations. Gonzalez AM, Trexler ET. J Strength Cond Res. 2020;34(5):1480-1495. PMID 31977835 DOI 10.1519/JSC.0000000000003426

Need this grade for your line?

RFQ